Researchers at Southern Medical University have identified that Bifidobacterium animalis, a common probiotic, secretes mannose to boost the effectiveness of melanoma immunotherapy. According to a study published in the May 2026 issue of Cancer Biology & Medicine, this sugar activates CD8⁺ T cells by targeting the Hippo-YAP1 signaling pathway, offering a potential new strategy to … Read more
Researchers at the Texas A&M Health Institute of Biosciences and Technology have developed a molecular switch called CODS (caffeine-operated dissociation system) that uses caffeine to control engineered cells. Published in the Journal of the American Chemical Society in 2026, the system allows scientists to trigger or pause gene-editing activity and immune cell responses on demand. … Read more
Breakthrough in Cancer Immunotherapy: How a Tiny Fraction of T Cells Could Revolutionize Multiple Myeloma Treatment By [Your Name], Cancer Immunotherapy Research Journalist Osaka, Japan — A groundbreaking study from researchers at Osaka University has uncovered a surprising truth about how the body fights cancer: in the battle against multiple myeloma, only a small group … Read more
The New Frontier of Immunotherapy: Reprogramming the Body to Fight Cancer For decades, vaccines have relied on adjuvants—substances added to a vaccine to create a stronger immune response. However, traditional adjuvants often provide only short-lived stimulation. A groundbreaking shift is now occurring, moving away from external triggers toward “reprogramming” the immune system from the inside … Read more